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ABSTRACT 
Objective: This work evaluated the influence of the technological properties of polyvinylpyrrolidone (PVP), calcium phosphate (CP) and cross-
linked sodium carboxymethylcellulose (CC) as well as the deposition of a solid dispersion, through the solvent evaporation method, on the 
technological parameters that define the properties of ibuprofen tablets. 
Methods: The powder flow rate through an orifice, bulk volume and tapped volume of powders, tablet hardness, disintegration time and dissolution 
profile of the tablets were determined on individual components, their physical mixtures, granules obtained by deposition and solvent evaporation, 
and tablets obtained at different compaction pressures.  
Results: The very poor flowability of CP and the high compactibility of PVP were transferred to the powder mixtures, which showed poor 
flowability, and ibuprofen tablets with twice the compactibility. The tablets disintegration was high with a low proportion of CC (0.5%), but 
decreased linearly by increasing the proportion of the disintegrant up to 10%. At the same time, the dissolution of the drug after 30 min increased 
from 3% to 80%. The agglomeration of CP through the deposition of an alcoholic solution of the drug and PVP improved the flow properties and 
tripled the hardness of the tablets. However, the dissolution after 30 min decreased from 80% to 18%. 
Conclusion: The physical mixture was the best option to improve the dissolution, while the deposition on an adsorbent, of a solid dispersion of 
drug-PVP, was the best option to improve the compactibility and flow properties. 
Keywords: Calcium phosphate, Croscarmellose sodium, Drug deposition, Ibuprofen tablets, polyvinylpyrrolidone, Solid dispersion, Technological 
performance 




The development of a pharmaceutical product involves compliance 
with the specifications of the desired product, the satisfaction of the 
requirement of a certain minimum stability and the fulfillment of the 
requirements that allow a fluid production process in the 
manufacturing. These requirements include compliance with 
product parameters such as compactibility, powder flowability, 
tablet disintegrability and dissolution rate.  
Tablets that require rapid disintegration include superdisintegrants. 
The choice of these disintegrants depends, among others, on the 
water solubility of the drug and the excipients of the tablet. Water-
soluble materials tend to dissolve rather than disintegrate, while 
insoluble materials generally disintegrate if an appropriate amount 
of disintegrant is included in the formulation [1].  
The development of fast disintegrating tablets includes the use of 
super-disintegrants that allow their disintegration after putting 
them in contact with the biological fluids. Super-disintegrants allow 
a quick action, which is beneficial in cases of acute pain [2]. 
The choice of the excipients is dependent of their physical and 
chemical properties and their technological functionality. This 
includes tests that address the chemical composition, tests that 
address the physical form of the materials, and tests that address 
their performance or functionality within the formulation and 
manufacturing process [3]. 
With respect to the paradigm of QbD, the variability of a 
pharmaceutical product is a function of the variability of the input 
variables. The determination of a formula, manufacturing 
operations, process parameters and product quality attributes can 
be defined as a function of the properties and technological 
performance of the materials. For the design of an effective product, 
it is necessary to have the ability to link the properties and 
technological performance of the materials to the functionality of the 
product [4]. 
Among others, the specific values of the technological properties of 
the excipient identify its functionality. These specific values allow 
the establishment of statistical parameters that determine how to 
use an excipient. These properties are also used to identify 
materials, for quality control purposes [5]. 
Ibuprofen is used to reduce fever and treat pain or inflammation 
caused by many conditions such as a headache, toothache, back pain 
or minor injuries. The main problems with ibuprofen are its low 
solubility in biological fluids, gastric irritation and a short half-life of 
2 h. The use of fast disintegrating tablets would help to improve the 
rate of dissolution and therefore the absorption [6]. 
To improve solubility, a number of methods have been employed, 
including solid dispersions, prodrugs, inclusion complexes and 
microcapsules [7]. 
A low aqueous solubility, as well as an inadequate dissolution rate of 
the drugs, is frequently overcome using amorphous systems. 
However, the high energy of the amorphous form is 
thermodynamically unstable, causing a return to the crystalline form 
with the consequent loss of solubility [8].  
Solid dispersions can be used to stabilize an amorphous system. In 
the case of flutamide, an increase in dissolution was attributed to the 
amorphization of the drug during the preparation of the solid 
dispersion [9]. 
Not only the rate of dissolution but the solubility can be modified 
with solid dispersions. The aqueous solubility of the drug carvedilol 
was increased up to 3.5 times in an aqueous solution of PVP K30 at 
5% w/v. This was attributed to the fact that the physical mixture 
increased the solubility and maximized the surface area of the drug 
that came into contact with the dissolution medium, when the 
transporter dissolved, while the solid dispersion produced a 
reduction in the crystallinity of the drug [10]. 
Similarly, in all aceclofenac-PVP solid dispersions, prepared by the rotary 
evaporation method, the dissolution rate of the drug was increased. The 
rate of dissolution increased with increasing PVP content [11]. 
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The aim of this work was the assessment of the influence of the 
formula composition and the preparation method on the 
technological parameters that define the tablet properties and the 
manufacturing behavior of ibuprofen tablets. 
MATERIALS AND METHODS 
Material 
Ibuprofen 38 (IBU) from BASF-USA, calcium phosphate (CP) from 
DROTASA-Mexico, polyvinylpyrrolidone, PVP-K30 (PVP) from 
Reasol-Mexico, cross-linked sodium carboxymethylcellulose (CC), 
croscarmellose sodium, from HELM-Mexico, magnesium stearate 
from HELM-Mexico, Aerosil 200 from Evonik Degussa-Mexico. All 
these materials were used as received. 
Mixtures preparation 
Physical mixtures 
In a glass mortar, the components were incorporated one by one 
while mixing with circular movements of the pestle. Mixture 
continued with circular movements until completing 20 min. The 
binary mixtures composition were equal parts of IBU with CP and 
PVP. The ternary mixture was prepared also with equal parts of IBU, 
CP and PVP. In every case, 1% of magnesium stearate was 
incorporated as a lubricant. Moreover, the ternary mixture was 
added of 0.5%, 1.0%, 3.0%, 6.0% and 10% CC.  
Imbibition or deposition on the adsorbent 
The corresponding amount of IBU is placed in a mortar, adding 
ethanol for its complete dissolution. Then, an equal amount of PVP is 
dissolved. Subsequently, the CP was added and kneaded until it was 
fully incorporated. The mass was allowed to dry at room 
temperature for a period of 3 h. Then it was passed through a 
number 20 mesh. The obtained granules were placed in an oven at 
50 °C for 60 min. The dried granules were placed in a V-type blender 
and the CC, the magnesium stearate and the Aerosil were added. The 
total amount was mixed at 30 rpm for 40 min. 
Bulk volume and tapped volume of powders 
The bulk volume of the poured powder was determined with 30 g 
of the corresponding material. The powder was poured gently 
through a funnel into a 100 ml graduated cylinder that was 
mounted on a tapper; recording the volume occupied by the 
powder (bulk volume-Vo). Once the total volume of powder was 
recorded, the graduated cylinder was tapped from a height of 1.5 
cm, by the tapper at a constant speed of 50 taps per minute. The 
tapping of the sample was carried out in cycles of 10 taps. The 
volume occupied by the powder was recorded, repeating the 
operation as necessary, until obtaining 3 consecutive equal 
measurements. This was the volume of the tapped powder (Vf). 
These measurements were repeated five times, sieving the 
powders through a number 20 mesh after each determination. 
With these measurements, the compressibility index was 
calculated. These procedures are similar to those used by other 
authors, although the equipment and operating conditions are 
different [12, 13]. 
Assessment of the flow rate of the powders 
Approximately 30 g of each material was placed in a glass funnel 
with a 7 mm opening that had been blocked. This funnel was placed 
on a 100 ml graduated cylinder mounted on a tapper. While 
unlocking the opening of the funnel, the tapper started moving. The 
powder flowed through the opening in the funnel, falling to the 
bottom of the cylinder. The time it takes to move the powder 
through the funnel was recorded. The powder flow rate was 
calculated by dividing the mass of the sample by the time recorded. 
The test was repeated 5 times, sieving the powder through a number 
20 mesh after each measurement. The average of the 5 repetitions 
was taken as the powder flow rate. 
Tablet preparation 
The tablets were obtained by compacting the powders for 20 s at a 
series of compaction pressures from 27 MPa to 163 MPa. For this 
purpose, a set of punches and matrix of 12.7 mm in diameter was 
used. The results recorded are the average of three repetitions. 
Compactibility assessment 
The crushing strength or tablet hardness was measured in triplicate; 
the results were recorded as an average. For this purpose, a tablet 
hardness tester Erweka TBH30-Germany was used. The procedure 
consisted of placing each tablet diametrically between two flat 
surfaces and applying pressure until the tablet breaks. The 
compactibility profile was described with an equation based on the 
Weibull distribution [14-16]: 
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Where D denotes the hardness or crushing strength of the tablet, 
Dmax the maximum hardness reached, Pc the compaction pressure, 
n the slope of the curve and I the intersection of the curve. 
Tablet disintegration 
To measure the disintegration time of the tablets, a TEMSA 
disintegration tester (TEMSA, Mexico City, Mexico) was used. In 
accordance with USP's disintegration procedures and using 900 ml 
of distilled water at 37 ° C. Disintegration tests were performed 
using the USP-type disintegration apparatus without disks. One 
tablet was placed in each of three individual tubes of the 
disintegration tester. The disintegration times of three tablets were 
determined and their average was recorded. 
Tablet dissolution 
The dissolution of the ibuprofen tablets was carried out in a 
type-USP II paddle apparatus. For this purpose, 500 mg tablets 
obtained at a compaction pressure of 109 MPa were used. The 
dissolution tester was adjusted to the temperature of 37 °C and 
50 rpm. As a dissolution medium, 900 ml of a phosphate buffer 
at a pH of 7.2 was used. Samples of 8 ml of each of three glasses 
were taken at different times, recovering the dissolution medium 
after each sample taking. The amount of dissolved drug was 
determined by reading the absorbance of each of the samples at 
a wavelength of 265 nm. The results recorded are the average of 
three tablets. The procedure was similar to that used by some 
other authors [17]. 
RESULTS AND DISCUSSION 
Flowability of raw materials 
The first part of the development of a pharmaceutical product 
includes the characterization of the materials used in the 
formulation. This characterization is useful as a reference of the 
properties of these materials, in order to control their quality. In 
addition, the characterization of the raw materials allows the 
inference of the possible uses of the excipients in the pharmaceutical 
formulation. 
Fig. 1 shows the flow properties of the powder of the materials used 
in the formulation of IBU tablets. The flow properties of the powder 
were determined by assessing the flow through an orifice and the 
compressibility index of the powder (CI). Both parameters agree to 
show intermediate rheological properties of IBU (CI=29.7%±3.3%), 
in comparison with those of PVP (CI=6.1%±1.2%) and CP 
(CI=42.9±0.6%). According to the powder compressibility index, 
both IBU as well as CP showed unsatisfactory rheological properties. 
As stated by the scale of flowability of powders, IBU displayed a poor 
powder flow, while CP showed a very poor powder flow.  
The compressibility index was calculated according to:  
Compressibility index = CI = 100 ∗ [Vo − Vf
Vo
] 
Where the volume occupied by a given mass of powder when 
allowed to settle freely, Vo, is related to the volume of the same 
mass of powder after sedimentation by tapping, Vf. The latter is 
obtained after tapping the material until it no longer changes its 
volume [18]. 
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Fig. 1: Flow properties of the powders included in the formulation 
of ibuprofen tablets: ibuprofen (IBU), polyvinylpyrrolidone (PVP), 
calcium phosphate (CP), data given in mean±SD, n=5 
 
Compactibility of raw materials 
Fig. 2 describes the characteristics of compactibility of the active 
principle and that of the two excipients to be used. The curves of 
compactibility showed the increase of the tablet hardness as the 
compaction pressure increased. The PVP compactibility curve shows 
the experimental points, their standard deviation and the calculated 
regression. PVP showed the highest compactibility, followed by CP 
while IBU showed the lowest capacity to form coherent tablets. 
 
 
Fig. 2: Compactibility curves of raw materials included in the 
ibuprofen tablets: ibuprofen (IBU), polyvinylpyrrolidone (PVP), 
calcium phosphate (CP), data are given in mean±SD, n=3 
 
 
Fig. 3: Effect of formula composition on the flow properties of 
the powders of ibuprofen tablets: ibuprofen (IBU), 
polyvinylpyrrolidone (PVP), calcium phosphate (CP), 
croscarmellose sodium (CC), data given in mean±SD, n=5 
Effect of the excipients on the flowability of ibuprofen 
Fig. 3 shows the effect of the different excipients on the flowability of 
the IBU powder. The powder mixtures were composed of equal 
parts of the components while the CC was added in a proportion of 
10%. As can be expected from the data of the excipients, CP 
increased the compressibility index of IBU, which means a lower 
flowability of the mixture. The subsequent addition of PVP reduced 
the compressibility index, improving the flow properties of the 
mixture. The final addition of CC to the aforementioned mixture 
again increased the compressibility index of the powder, reducing its 
flowability, to almost the same level as IBU alone. The poor flow 
properties of the powder blend generated by an excipient (CP) can 
be compensated by the addition of a more fluid powder (PVP). 
Effect of the excipients on compactibility of ibuprofen 
Fig. 4 shows the effect of the different excipients on the poor 
compactibility of IBU. This fig. displays the experimental points and 
the calculated regressions. In particular, the curve corresponding to 
the mixture of IBU-CP-PVP also includes the standard deviation of 
the experimental points. In all the following figures, the 
experimental points of at least one curve show their standard 
deviation. Although CP showed a better compactibility than IBU, its 
mixture did not appreciably change the compactibility profile. The 
drug maintained practically the same compactibility profile. 
However, the addition of PVP to the above mixture showed a 
considerable increase in the compactibility, due to the greater 
compactibility of the PVP and perhaps to its plastic behavior during 
compression. As a cellulose derivative, CC exhibits appreciable 
compactibility properties, although not as good as those of PVP. 
After its addition to the previous mixture, CC slightly reduced 
compactibility of the mixture. The observed effect of the excipients 
was related not only to its compactibility but also to its compacting 
mechanism. Blends of brittle materials with plastically deforming 
materials provide mixtures with greater compactibility. 
 
 
Fig. 4: Effect of formula composition on the compactibility curve 
of ibuprofen tablets: ibuprofen (IBU), polyvinylpyrrolidone 
(PVP), calcium phosphate (CP), croscarmellose sodium (CC), 
data given in mean±SD, n=3 
 
Effect of the excipients on the release profile of ibuprofen 
tablets 
The admixture of equal parts of IBU and CP exhibited the lower 
dissolution profile. The subsequent addition of PVP, producing 
mixtures of equal parts of each excipient and the drug, did not better 
the dissolution behavior. The drug release profile was similar to that 
of tablets without PVP (fig. 5).  
The effect of PVP on the tablet dissolution had been observed earlier 
in oxytetracycline dihydrate tablets. Tablets that were obtained by 
wet granulation, with a PVP solution, showed that the increase in 
PVP concentration in the binder solution decreased the dissolution 
rate of the tablets [19]. 
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Similarly, the caffeine tablets obtained using a wet granulation 
method and with PVP contents of 1, 2.5, 5 and 10% showed that the 
dissolution rate of the drug decreased with the increase in the 
proportion of the binder (PVP). The fastest dissolution of the active 
substance took place with the lowest amount of PVP (1% w/w) in 
the tablet [20]. 
However, the Addition of CC which is an excipient used as tablet and 
capsule disintegrant showing wicking and swelling abilities 
increased importantly the drug dissolution. IBU tablets containing 
10% CC showed the higher dissolution rate of all tablets studied. As 
can be seen in fig. 5, the use of CC allowed the dissolution of 
approximately 85% IBU after 30 min dissolution. 
 
 
Fig. 5: Effect of formula composition on the dissolution profile of 
ibuprofen tablets obtained by applying a compaction pressure of 
109 MPa: polyvinylpyrrolidone (PVP), calcium phosphate (CP), 
croscarmellose sodium (CC), data given in mean±SD, n=3 
 
 
Fig. 6: Effect of compaction pressure and croscarmellose 
sodium (CC) content on the curve of disintegration time of 
ibuprofen tablets, data given in mean±SD, n=3 
 
Effect of the excipients on the disintegration profile of 
ibuprofen tablets 
The disintegration test is a test that helps in the optimization of 
manufacturing variables, such as compression force and dwell time. 
This test is also a parameter for quality control of the tablets and for 
checking the consistency between different batches. 
In this part of the study, the effect of different compaction pressures 
and different proportions of the disintegrant CC on disintegration 
time of IBU tablets was investigated. 
Fig. 6 shows the relationship between the compaction pressure and 
the disintegration time of the tablets containing different 
proportions of the disintegrant and equal parts of CP, PVP and IBU, 
added with 1% magnesium stearate. The points in fig. 6 are 
experimental and include, in the case of the formula containing 6% 
CC, the observed standard deviation for the individual values. These 
tablets were obtained by direct compression of the powder 
mixtures. As can be seen in the graph, there is a linear tendency to 
increase the disintegration time as the compaction pressure 
increases. This occurred in all the different formulations studied that 
contain different proportions of the disintegrant. 
Fig. 7 shows a linear relationship between the proportion of CC in 
the formulations and the disintegration time of the tablets. The 
tablets studied were obtained by direct compression at a 
compaction pressure of 109 MPa. 
The progressive increase in the proportion of the disintegrant 
gradually decreased the disintegration time of the tablets. This 
tendency was maintained at all the used proportions of the 
disintegrant. This occurred even though other studies have found an 
increase in the disintegration time of the tablets after exceeding a 
threshold proportion of 2 % CC for CP tablets. This threshold was 
attributed to the fact that increasing the amount of CC in the 
formulation also increased the hardness of the tablets [21]. In the 
same way, it was observed that increasing concentrations of the 
disintegrant Starch 1500 increased the percentage of Norfloxacin 
dissolved after 30 min, until a maximum is reached at about 12% 
Starch 1500. After this maximum, the dissolved Norfloxacin 
decreased. This behavior was considered as normal for a substance 
that acts promoting disintegration and, at the same time, works as a 
direct compression binder [22].  
 
 
Fig. 7: Effect of croscarmellose sodium content on the 
disintegration time of ibuprofen tablets compacted at 109 MPa, 
data given in mean±SD, n=3 
 
Effect of the excipients and processing on the flowability of 
ibuprofen 
During the early stages of development of a pharmaceutical product, 
it may be important to understand the influence of the processing 
technique on the performance of the solid dispersion to ensure the 
selection of a suitable formulation and processing technique. 
The flow properties of the mixture of equal parts of IBU, CP or PVP, 
added of 10% CC (fig. 3) could be improved by including an 
agglomeration operation. This operation included the formation of a 
solid dispersion of the drug. An alcoholic solution of the drug and 
PVP was embedded or deposited on CP, with and without 
subsequent addition of Aerosil. The solid dispersions were prepared 
by the solvent evaporation technique. 
It can be observed in fig. 8 that the agglomeration by imbibition or 
deposition of solutions of IBU-PVP on CP decreased the 
compressibility index of the powder of the physical mixture. The 
addition of Aerosil, after the deposition of the solution, further 
decreased the compressibility index of the physical mixture. 
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Correspondingly, the powder flow rate of the physical mixture 
increased after preparation of the solid dispersion by imbibition or 
deposition on CP, increasing even more after deposition on CP plus 
the subsequent addition of Aerosil. 
 
 
Fig. 8: Effect of preparation method and formula composition 
on the flow properties of powders of ibuprofen tablets, data 
given in mean±SD, n=5 
 
Solid dispersions of furosemide showed similar results. The 
formulation of the solid dispersion included furosemide with 
polyethene glycol 6000 and microcrystalline cellulose as the 
adsorbent. The powders of the solid dispersions showed an angle of 
repose that gradually decreased as the proportion of the adsorbent 
increased [23]. 
Effect of the excipients and processing on compactibility of 
ibuprofen 
In solid dispersions obtained by spray drying of a drug with PVP VA64 
(1:2), it was observed that at any porosity of the tablets, the ground 
physical mixture showed a higher tensile strength compared to the 
solid dispersions. This was attributed to the loss of lattice and weaker 
forces between the glassy particles in the solid dispersions [24]. 
In contrast to the above, fig. 9 shows a greater compactibility of the 
mixtures obtained by the process of imbibition or deposition of a 
solution of the drug and PVP on CP, to obtain a solid dispersion. It is 
noteworthy that the tablets obtained with the solid dispersions 
behaved plastically, avoiding an accurate determination of their 
tensile strength. The tablets deformed slowly before breaking or 
simply reached the measurement limit of the hardness tester and 
did not break at all. 
 
 
Fig. 9: Effect of formula composition and preparation method 
on the compactibility curve of ibuprofen tablets, data given in 
mean±SD, n=5 
In the present case, it is considered that the material exposed to the 
compression forces is the PVP since it covers the adsorbent material. 
Therefore, the compaction capacity of the tablets can be referred to 
this material, which, as seen in fig. 2, has a high compaction capacity. 
However, the higher tensile strength of current tablets can also be 
attributed to the fact that PVP was mixed with a material such as CP 
that breaks up during compression. CP is widely fragmented, 
improving the filling of the empty spaces during compression, which 
leads to an optimum use of the compaction force [25]. 
The use of a combination of a material that deforms plastically with 
another that fragments should guarantee a greater compactibility. It 
seems that the mixture can have advantages over the individual 
materials. The inclusion of Aerosil in the formulation increased the 
previous effect facilitating the sliding of the particles during 
compression. 
Effect of the excipients and processing on the release profile of 
ibuprofen tablets 
It has been reported in the literature that the combination of a 
hydrophilic polymeric vehicle such as PVP could improve the 
solubility as well as the dissolution rate of poorly water-soluble 
drugs. The solid dispersions of IBU with PVP (1:1 and 1:2) showed a 
higher saturation solubility compared to pure IBU. The in vitro 
dissolution profiles of solid dispersion samples also showed greater 
dissolution than that of pure IBU. The solid dispersions of IBU with 
PVP showed a dissolution of approximately 65% after 60 min [26].  
The greater dissolution of IBU was attributed to greater wettability 
due to the higher level of hydrophilicity obtained with the use of the 
polymeric vehicle. In addition, the results suggested that the greater 
dissolution of IBU from the solid dispersion was also due to the 
presence of the drug in an amorphous state, compared to the pure 
drug, where the drug was present in the crystalline state. 
With vehicles other than PVP, it was observed that the rate of 
dissolution of IBU tablets was improved by the solid dispersions 
obtained with urea. The results of the characterization of the solid 
dispersions suggested that IBU partially precipitated in crystalline and 
amorphous forms after the preparation of the solid dispersion [27].  
Contrasting with the higher dissolution from the above-mentioned 
solid dispersions, fig. 10 shows the dissolution profile of IBU tablets 
containing equal parts of PVP, CP and IBU, added of 10% CC. The 
release profile of the physical mixture attained almost 100% 
dissolution of the drug after 60 min. The tablets obtained from solid 
dispersions deposited on CP showed a dissolution after 60 min of 
46%, while the tablets obtained from a solid dispersion deposited on 
CP plus the subsequent addition of 2% Aerosil showed a similar 
dissolution profile, the drug dissolved after 60 min was 42%. 
 
 
Fig. 10: Effect of formula composition and preparation method 
on the dissolution profile of ibuprofen tablets, data given in 
mean±SD, n=3 
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The processing of the physical mixture to deposit an alcoholic 
solution of the drug and PVP on CP or on CP plus the subsequent 
addition of Aerosil did not produce an increase in the dissolution of 
the drug from the tablets, but a decrease. 
A similar situation was observed with solid dispersions of valsartan 
with HPMC. The solid dispersions showed film formation during the 
preparation. The formation of such a film made it difficult to release 
the drug from the formulation [28]. 
Similarly, tablets of solid dispersion formulations of the anti-HIV 
drug UC 781 with HPMC 2910 showed a slow dissolution process 
due to the gelation of the polymer. The drug was released slowly as 
HPMC 2910 dissolved in the medium. In this case, 90% of the drug 
dissolved after 4 h [29]. 
Although a higher dissolution rate of the solid dispersions of 
ibuprofen in PVP has been observed, this has been observed in 
samples in powder form [26]. Currently, the compaction process had 
a negative influence on the dissolution. The tablets obtained showed 
a high mechanical strength and behaved plastically, which 
significantly increased the disintegration time (fig. 11). The tablets 
obtained with solid dispersions formed a matrix of PVP that rather 
dissolves instead of disintegrating. 
 
 
Fig. 11: Effect of formula composition and preparation method 
on the curve of disintegration time of ibuprofen tablets, data 
given in mean±SD, n=3 
 
CONCLUSION 
The characterization of the technological properties of the materials 
is useful to control their quality and allows the inference of their 
possible uses in the pharmaceutical formulation. 
The technological properties of the materials are transferred to their 
powder mixtures and their tablets. The poor technological 
properties of a material can be compensated by adding another with 
better functionality. 
The progressive increase in the proportion of CC up to 10% linearly 
decreased the disintegration time of the tablets, although other 
studies have found an increase in the disintegration time of the 
tablets after exceeding a threshold proportion of the disintegrant. 
Unlike other reports, the formation of a solid dispersion of IBU-PVP, 
by imbibition or deposition on an adsorbent, did not improve the 
dissolution but deteriorated it. This was attributed to a significant 
increase in the compaction capacity of the agglomerated material, 
forming a matrix of PVP that dissolves rather than disintegrates. 
The physical mixture was the best option to improve the dissolution, 
while the deposition of a solid dispersion of IBU-PVP on an adsorbent 
was the best option to improve the compactability and flow properties. 
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